Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children

Detalhes bibliográficos
Autor(a) principal: Olímpio, Hugo de Oliveira
Data de Publicação: 2014
Outros Autores: Bustorff-Silva, Joaquim, Oliveira Filho, Antonio Gonçalves de, Araujo, Kleber Cursino de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/83966
Resumo: OBJECTIVE: Here, we describe our experience with different therapeutic modalities used to treat cystic lymphangiomas in children in our hospital, including single therapy with OK-432, bleomycin and surgery, and a combination of the three modalities. METHODS: We performed a retrospective, cross-sectional study including patients treated from 1998 to 2011. The effects on macrocystic lymphangiomas and adverse reactions were evaluated. Twenty-nine children with cystic lymphangiomas without any previous treatment were included. Under general anesthesia, patients given sclerosing agents underwent puncture of the lesion (guided by ultrasound when necessary) and complete aspiration of the intralesional liquid. The patients were evaluated with ultrasound and clinical examinations for a maximum follow-up time of 4 years. RESULTS: The proportions of patients considered cured after the first therapeutic approach were 44% in the surgery group, 29% in the bleomycin group and 31% in the OK-432 group. These proportions were not significantly different. Sequential treatment increased the rates of curative results to 71%, 74% and 44%, respectively, after the final treatment, which in our case was approximately 1.5 applications per patient. CONCLUSION: The results of this study indicate that most patients with cystic lymphangiomas do not show complete resolution after the initial therapy, regardless of whether the therapy is surgical or involves the use of sclerosing agents. To achieve complete resolution of the lesions, either multiple operations or a combination of surgery and sclerotherapy must be used and should be tailored to the characteristics of each patient.
id USP-19_d16c6a5350f694c6186487ebdf3f7d1f
oai_identifier_str oai:revistas.usp.br:article/83966
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children OBJECTIVE: Here, we describe our experience with different therapeutic modalities used to treat cystic lymphangiomas in children in our hospital, including single therapy with OK-432, bleomycin and surgery, and a combination of the three modalities. METHODS: We performed a retrospective, cross-sectional study including patients treated from 1998 to 2011. The effects on macrocystic lymphangiomas and adverse reactions were evaluated. Twenty-nine children with cystic lymphangiomas without any previous treatment were included. Under general anesthesia, patients given sclerosing agents underwent puncture of the lesion (guided by ultrasound when necessary) and complete aspiration of the intralesional liquid. The patients were evaluated with ultrasound and clinical examinations for a maximum follow-up time of 4 years. RESULTS: The proportions of patients considered cured after the first therapeutic approach were 44% in the surgery group, 29% in the bleomycin group and 31% in the OK-432 group. These proportions were not significantly different. Sequential treatment increased the rates of curative results to 71%, 74% and 44%, respectively, after the final treatment, which in our case was approximately 1.5 applications per patient. CONCLUSION: The results of this study indicate that most patients with cystic lymphangiomas do not show complete resolution after the initial therapy, regardless of whether the therapy is surgical or involves the use of sclerosing agents. To achieve complete resolution of the lesions, either multiple operations or a combination of surgery and sclerotherapy must be used and should be tailored to the characteristics of each patient. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/8396610.6061/clinics/2014(08)01Clinics; Vol. 69 No. 8 (2014); 505-508Clinics; v. 69 n. 8 (2014); 505-508Clinics; Vol. 69 Núm. 8 (2014); 505-5081980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/83966/86798Olímpio, Hugo de Oliveira Bustorff-Silva, Joaquim Oliveira Filho, Antonio Gonçalves de Araujo, Kleber Cursino de info:eu-repo/semantics/openAccess2014-08-26T22:46:18Zoai:revistas.usp.br:article/83966Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2014-08-26T22:46:18Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
title Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
spellingShingle Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
Olímpio, Hugo de Oliveira
title_short Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
title_full Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
title_fullStr Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
title_full_unstemmed Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
title_sort Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children
author Olímpio, Hugo de Oliveira
author_facet Olímpio, Hugo de Oliveira
Bustorff-Silva, Joaquim
Oliveira Filho, Antonio Gonçalves de
Araujo, Kleber Cursino de
author_role author
author2 Bustorff-Silva, Joaquim
Oliveira Filho, Antonio Gonçalves de
Araujo, Kleber Cursino de
author2_role author
author
author
dc.contributor.author.fl_str_mv Olímpio, Hugo de Oliveira
Bustorff-Silva, Joaquim
Oliveira Filho, Antonio Gonçalves de
Araujo, Kleber Cursino de
description OBJECTIVE: Here, we describe our experience with different therapeutic modalities used to treat cystic lymphangiomas in children in our hospital, including single therapy with OK-432, bleomycin and surgery, and a combination of the three modalities. METHODS: We performed a retrospective, cross-sectional study including patients treated from 1998 to 2011. The effects on macrocystic lymphangiomas and adverse reactions were evaluated. Twenty-nine children with cystic lymphangiomas without any previous treatment were included. Under general anesthesia, patients given sclerosing agents underwent puncture of the lesion (guided by ultrasound when necessary) and complete aspiration of the intralesional liquid. The patients were evaluated with ultrasound and clinical examinations for a maximum follow-up time of 4 years. RESULTS: The proportions of patients considered cured after the first therapeutic approach were 44% in the surgery group, 29% in the bleomycin group and 31% in the OK-432 group. These proportions were not significantly different. Sequential treatment increased the rates of curative results to 71%, 74% and 44%, respectively, after the final treatment, which in our case was approximately 1.5 applications per patient. CONCLUSION: The results of this study indicate that most patients with cystic lymphangiomas do not show complete resolution after the initial therapy, regardless of whether the therapy is surgical or involves the use of sclerosing agents. To achieve complete resolution of the lesions, either multiple operations or a combination of surgery and sclerotherapy must be used and should be tailored to the characteristics of each patient.
publishDate 2014
dc.date.none.fl_str_mv 2014-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/83966
10.6061/clinics/2014(08)01
url https://www.revistas.usp.br/clinics/article/view/83966
identifier_str_mv 10.6061/clinics/2014(08)01
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/83966/86798
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 69 No. 8 (2014); 505-508
Clinics; v. 69 n. 8 (2014); 505-508
Clinics; Vol. 69 Núm. 8 (2014); 505-508
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222761235251201